Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
US Army
Citi
Cipla
Federal Trade Commission
Queensland Health
Fuji
Cantor Fitzgerald
Boehringer Ingelheim

Generated: October 19, 2017

DrugPatentWatch Database Preview

Memantine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for memantine hydrochloride and what is the scope of memantine hydrochloride patent protection?

Memantine hydrochloride
is the generic ingredient in three branded drugs marketed by Sun Pharma Global, Unichem Labs Ltd, Amneal Pharms, Forest Labs Llc, Mylan Pharms Inc, Lupin Ltd, Ajanta Pharma Ltd, Silarx Pharms Inc, Apotex Inc, Macleods Pharms Ltd, Upsher-smith Labs, Orchid Hlthcare, Bio-pharm Inc, Dr Reddys Labs Ltd, Strides Pharma, Teva Pharms, Puracap Pharm Llc, Torrent Pharms Ltd, Zydus Pharms Usa Inc, Wockhardt Ltd, Aurobindo Pharma Ltd, Anchen Pharms, Jubilant Generics, and Alembic Pharms Ltd, and is included in thirty-three NDAs. There are seven patents protecting this compound and five Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for memantine hydrochloride. Thirty-eight suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: memantine hydrochloride

US Patents:7
Tradenames:3
Applicants:24
NDAs:33
Drug Master File Entries: see list28
Suppliers / Packagers: see list38
Bulk Api Vendors: see list69
Clinical Trials: see list2,457
Patent Applications: see list2,088
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:memantine hydrochloride at DailyMed

Pharmacology for Ingredient: memantine hydrochloride

Tentative approvals for MEMANTINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
u► Subscribe5MGTABLET; ORAL
u► Subscribe10MGTABLET; ORAL
u► Subscribe10MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-002Jun 21, 2010ABRXYesNo► Subscribe► SubscribeY► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-003Jun 21, 2010ABRXYesNo► Subscribe► SubscribeY► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-001Jun 21, 2010ABRXYesNo► Subscribe► Subscribe► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-002Jun 21, 2010ABRXYesNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205905-003Sep 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL206028-002Sep 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Anchen Pharms
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205784-002Jun 9, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205825-003Oct 12, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-004Jun 21, 2010ABRXYesYes► Subscribe► SubscribeY► Subscribe
Wockhardt Ltd
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL090073-001Sep 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: memantine hydrochloride

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Harvard Business School
Teva
Argus Health
Cantor Fitzgerald
McKesson
UBS
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot